Clinical Trials
25 trialsNCT04381806 2026-05-22
Phase I Study in Advanced Malignancies With 5-ALA
Fox Chase Cancer Center
Phase 1 Suspended
NCT05155332 2026-05-20
A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors)
Boehringer Ingelheim
Phase 1 Suspended
NCT05206942 2026-05-06
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
Stanford University
Phase NA Suspended
NCT05337735 2026-05-04
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT05960773 2026-05-04
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
National Institutes of Health Clinical Center (CC)
Phase 2 Suspended
NCT07529535 2026-04-17
A First-in-Human Study of ALK-N001 for Injection in Patients With Advanced Solid Tumors
Zhejiang Anglikang Pharmaceutical Co., Ltd.
Phase 1 Suspended
NCT06508034 2026-01-21
Probiotics for the Prevention of Immunotherapy Induced Colitis in Patients Receiving Immunotherapy
Mayo Clinic
Phase NA Suspended
NCT05844306 2025-11-19
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
City of Hope Medical Center
Phase NA Suspended
NCT05938296 2025-11-19
oHSV2-PD-L1/CD3-BsAb Administered Via Intratumoral Injection
Binhui Biopharmaceutical Co., Ltd.
Phase 1 Suspended
NCT06581211 2025-11-06
Aromatherapy Oil Associated for Managing Anxiety and Pain During Bone Marrow Biopsy Procedures
City of Hope Medical Center
Phase NA Suspended
NCT04031469 2025-07-31
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
Suspended
NCT05055518 2025-06-27
APL-102 Capsule in Patients With Advanced Solid Tumors
Apollomics Inc.
Phase 1 Suspended
NCT05571969 2025-05-07
Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
Allarity Therapeutics
Phase 1 Suspended
NCT04485416 2025-04-10
CCPO011
University of California, Davis
Phase 1 Suspended
NCT05416749 2024-11-20
A Clinical Study of 8MW2311 in Subjects With Locally Advanced or Metastatic Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Suspended
NCT05076591 2024-10-30
IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Suspended
NCT03859752 2023-09-22
TR1801-ADC in Patients With Tumors That Express c-Met
Open Innovation Partners, Inc.
Phase 1 Suspended
NCT01627795 2018-04-18
Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Oshadi Drug Administration
Phase 1/2 Suspended
NCT00695032 2014-11-05
Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors
Institut Claudius Regaud
Phase NA Suspended
NCT01762410 2014-09-29
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
Piramal Enterprises Limited
Phase 1 Suspended
NCT01779336 2014-09-29
Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors
Piramal Enterprises Limited
Phase 1 Suspended
NCT01604863 2012-11-01
A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
GlaxoSmithKline
Phase 1 Suspended
NCT00003980 2012-07-11
BIBX 1382 in Treating Patients With Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1 Suspended
NCT01226056 2010-10-21
Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets
Southern Europe New Drug Organization
Phase 1/2 Suspended
NCT00591682 2008-03-26
MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Metastatix, Inc.
Phase 1 Suspended